EORTC PhD fellow Emma Willems addresses how do leaders of international non-profit organizations deal with resource pressures caused by the COVID-19 pandemic
10 Nov 2022
Since 1991, the EORTC Fellowship Program enables physicians, statisticians and scientists from around the world to engage in clinical research that advances the EORTC’s evolving scientific strategy in the fight against cancer. Support for the EORTC Fellowship Programme comes from several sources, and more than 190 fellowships covering 35 countries have been awarded so far.
Emma L. Willems, a PhD fellow at EORTC funded by the EORTC’s Cancer Research Fund (ECRF), has co-authored an article that was recently published in the Journal of Contingencies and Crisis Management.
In their article, Emma L. Willems, Stijn Van Puyvelde, Marc Jegers and Peter Raeymaeckers overview the challenges experienced by international non-profits during the COVID-19 pandemic and investigate the responsive actions of the leadership (board of directors and managerial executive) to the health crisis. The results indicate resource decreases in nearly all stakeholder channels. In response, non-profit boards increased activity levels by mainly focusing on adapting organizational offerings and increasing support to the organization. Managerial executives also increased their activity levels, by focusing on safeguarding financial stability, planning and adapting operations to confinement measures.
You can read the full article here.
Related News
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
